← Latest Filings
N

Neervannan Seshadri

Chief Operating Officer

Open-market buys
0
$0 total
Open-market sells
6
$2.0M total
Tracking since
Mar 2026
Activity timeline
Open-market sale — $388K
Tarsus Pharmaceuticals, Inc. · Sep 4, 2026
Open-market sale — $200K
Tarsus Pharmaceuticals, Inc. · Mar 20, 2026
Open-market trades from the last two years.

4 more trades. A free account shows you more; Premium shows every one.

Log in
Holdings as last reported
78,532 Common Stock in TARS
Held directly · as of 2026-09-04
27,310 Stock Option (right to buy) in TARS
Held directly · as of 2026-03-05

2 more holdings. A free account shows you more; Premium shows every one.

Log in
Companies touched
Tarsus Pharmaceuticals, Inc.
CIK 0001819790